3 ms·
According to the article, it occured between 2009 and 2014. Not sure exactly how much profit they made off of it and it's probably not easy to find out, but of
by missedthecue 4y ago
According to the article, it occured between 2009 and 2014. Not sure exactly how much profit they made off of it and it's probably not easy to find out, but of the three drugs they marketed in unlawful ways, Tysabri for instance had US sales of $58m in the 08-09 year. And that's sales not pure profit after costs.
- CountSessine 4y agoAsk and ye shall receive: Biogen annual net income for the year ending... 2010-June-30: $1094M 2011-June-30: $1076M 2012-June-30: $1342M 2013-June-30: $1608M 2014-June-30: $2140M 2015-June-30: $3490M Also, because someone asked, edgar has a bar chart breakdown of Biogen's product revenue. The lawsuit was about Biogen's drugs Avonex, Tysabri and Tecfidera. The bar chart (https://www.sec.gov/Archives/edgar/data/875045/000087504515000005/biib-2014pincipalproduct.jpg https://www.sec.gov/Archives/edgar/data/875045/0000875045150...) seems to indicate that these three were responsible for about 80-83% of Biogen's revenues (and presumably net income?) in 2014. I guess what we don't know is what their sales would have been like without the kickbacks? Less, presumably? But 0? Probably not.